Abstract
Sixteen patients with tardive dyskinesia were treated with vitamin E in an open trial of on-off-on design. Abnormal involuntary movement scale (AIMS) ratings were performed in every phase of the study. The patients exhibited a significant reduction in their mean AIMS score during vitamin E treatment. Thus, this finding may suggest a possible role for vitamin E in the treatment of tardive dyskinesia.
| Original language | English |
|---|---|
| Pages (from-to) | 217-220 |
| Number of pages | 4 |
| Journal | Human Psychopharmacology |
| Volume | 12 |
| Issue number | 3 |
| DOIs | |
| State | Published - May 1997 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Abnormal involuntary movement scale (AIMS)
- Tardive dyskinesia
- Vitamin E
Fingerprint
Dive into the research topics of 'Vitamin E treatment in tardive dyskinesia'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver